相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans
Manuel Cuenca-Estrella et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Infections caused by Scedosporium spp.
Karoll J. Cortez et al.
CLINICAL MICROBIOLOGY REVIEWS (2008)
Successful control of Scedosporium prolificans septic arthritis and probable osteomyelitis without radical surgery in a long-term renal transplant recipient
J. Y. Z. Li et al.
TRANSPLANT INFECTIOUS DISEASE (2008)
Molecular typing of Australian Scedosporium isolates showing genetic variability and numerous S-aurantialcum
Laurence Delhaes et al.
EMERGING INFECTIOUS DISEASES (2008)
New and emerging treatments for fungal infections
A. C. Pasqualotto et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Infection with Scedosporium apiospermum and S-prolificans, Australia
Louise Cooley et al.
EMERGING INFECTIOUS DISEASES (2007)
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease
Andrew J. Ullmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Scedosporium prolificans brain abscess in a patient with chronic granulomatous disease: Successful combination therapy with vorieonazole and terbinafine
Sunil V. Bhat et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2007)
Changing epidemiology of rare mould infections - Implications for therapy
Anurag N. Malani et al.
DRUGS (2007)
Treatment of solid organ transplant patients with invasive fungal infections:: should a combination of antifungal drugs be used?
Patricia Munoz et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2006)
Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients
Zahida Bhatti et al.
MYCOPATHOLOGIA (2006)
Interferon-γ therapy in two patients with progressive chronic pulmonary aspergillosis
P. Kelleher et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi
M Cuenca-Estrella et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Immunomodulation with interferon-gamma and colony-stimulating factors for refractory fungal infections in patients with leukemia
MC Dignani et al.
CANCER (2005)
Inteferon gamma and granulocyte-macrophage colony-stimulating factor augment the antifungal activity of human polymorphonuclear leukocytes against Scedosporium spp.:: comparison with Aspergillus spp.
C Gil-Lamaignere et al.
MEDICAL MYCOLOGY (2005)
Disseminated Scedosporium prolificans infection and survival of a child with acute lymphoblastic leukemia
M Whyte et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2005)
Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: Clinical characteristics and impact of antifungal agent therapy on outcome
S Husain et al.
CLINICAL INFECTIOUS DISEASES (2005)
Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole
A Imhof et al.
CLINICAL INFECTIOUS DISEASES (2004)
Antifungal activities of posaconazole and granulocyte-macrophage colon-stimulating factor ex vivo and in mice with disseminated infection due to Scedosporium prolificans
M Simitsopoulou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery
IB Gosbell et al.
MYCOSES (2003)
Efficacy of albaconazole (UR-9825) in treatment of disseminated Scedosporium prolificans infection in rabbits
J Capilla et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedospotium prolificans isolates
J Meletiadis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Emerging moulds: Fusarium, Scedosporium and Zygomycetes in transplant recipients
M Nucci
CURRENT OPINION IN INFECTIOUS DISEASES (2003)
Scedosporium species infections and treatments
WJ Steinbach et al.
JOURNAL OF CHEMOTHERAPY (2003)
Amphotericin B lipid complex exerts additive antifungal activity in combination with polymorphonuclear leucocytes against Scedosporium prolificans and Scedosporium apiospermum
C Gil-Lamaignere et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Antifungal Triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum
C Gil-Lamaignere et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Disseminated phaeohyphomycosis: Review of an emerging mycosis
SG Revankar et al.
CLINICAL INFECTIOUS DISEASES (2002)
Disseminated infection and colonization by Scedosporium prolificans:: A review of 18 cases, 1990-1999
P Idigoras et al.
CLINICAL INFECTIOUS DISEASES (2001)
Disseminated infection by Scedosporium prolificans:: an emerging fatality among haematology patients.: Case report and review
J Maertens et al.
ANNALS OF HEMATOLOGY (2000)